| RS1881807337 |
FOXG1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1881808715 |
FOXG1
|
Health Risk |
Pathogenic/Likely pathogenic |
FOXG1 disorder, FOXG1 disorder |
| RS1881809272 |
FOXG1
|
Health Risk |
Likely pathogenic |
FOXG1 disorder, FOXG1 disorder |
| RS1881812495 |
FOXG1
|
Health Risk |
Pathogenic |
— |
| RS1881815891 |
FOXG1
|
Health Risk |
Likely pathogenic |
FOXG1 disorder, FOXG1 disorder |
| RS1881816066 |
FOXG1
|
Health Risk |
Pathogenic |
FOXG1 disorder, FOXG1 disorder |
| RS1881817310 |
FOXG1
|
Health Risk |
Pathogenic |
FOXG1 disorder, Inborn genetic diseases |
| RS1881819022 |
FOXG1
|
Health Risk |
Pathogenic |
FOXG1 disorder, FOXG1 disorder |
| RS1881820386 |
FOXG1
|
Health Risk |
Pathogenic |
— |
| RS188182072 |
SALL1
|
Health Risk |
Pathogenic |
Townes syndrome, Townes syndrome |
| RS1881828200 |
FOXG1
|
Health Risk |
Pathogenic |
FOXG1 disorder, Neurodevelopmental disorder |
| RS188182890 |
BLTP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alkuraya-Kucinskas syndrome, BLTP1-related disorder |
| RS188184732 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, COL6A2-related disorder |
| RS188185141 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1881865054 |
SGCG
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2C, Autosomal recessive limb-girdle muscular dystrophy type 2C |
| RS188188069 |
FAT1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS188188906 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, Inborn genetic diseases |
| RS188194665 |
SGPL1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS188198404 |
MYO7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 2, Autosomal dominant nonsyndromic hearing loss 11 |
| RS188202707 |
LAMA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS188203905 |
RPGRIP1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 8, Joubert syndrome 7 |
| RS1882052778 |
PNP
|
Health Risk |
Likely pathogenic |
Purine-nucleoside phosphorylase deficiency, Purine-nucleoside phosphorylase deficiency |
| RS188208167 |
AFF2
|
Health Risk |
Likely pathogenic |
Premature ovarian failure, Premature ovarian failure |
| RS1882116704 |
PNP
|
Health Risk |
Pathogenic |
Purine-nucleoside phosphorylase deficiency, Purine-nucleoside phosphorylase deficiency |
| RS1882120489 |
SLC25A15
|
Health Risk |
Likely pathogenic |
Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome |
| RS1882123662 |
SLC25A15
|
Health Risk |
Likely pathogenic |
— |
| RS1882127556 |
SLC25A15
|
Health Risk |
Likely pathogenic |
Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome |
| RS188212919 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Heterotopia, periventricular |
| RS188214239 |
SCN3A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS188216614 |
FLNB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1882179247 |
KIF5A
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS188218914 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 3, Primary ciliary dyskinesia |
| RS1882201496 |
TPP2
|
Health Risk |
Pathogenic |
Evans syndrome, immunodeficiency |
| RS1882225878 |
COL4A2
|
Health Risk |
Likely pathogenic |
— |
| RS1882232971 |
ERCC5
|
Health Risk |
Pathogenic/Likely pathogenic |
Xeroderma pigmentosum, group G |
| RS1882233400 |
SLC25A15
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome |
| RS1882272161 |
KIF5A
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1882296594 |
SLC25A15
|
Health Risk |
Pathogenic |
Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome |
| RS1882296805 |
SLC25A15
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, SLC25A15-related disorder |
| RS1882325267 |
TPP2
|
Health Risk |
Pathogenic |
Immunodeficiency 78 with autoimmunity and developmental delay, Immunodeficiency 78 with autoimmunity and developmental delay |
| RS188233679 |
KY
|
Health Risk |
Conflicting classifications of pathogenicity |
KY-related disorder, Inborn genetic diseases |
| RS188234466 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Myopathy |
| RS188245182 |
KRT4
|
Health Risk |
Conflicting classifications of pathogenicity |
White sponge nevus 1, Inborn genetic diseases |
| RS188246267 |
AIPL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 4, Leber congenital amaurosis 4 |
| RS188247308 |
PCARE
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS188247474 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Amyotrophic lateral sclerosis type 4 |
| RS188248622 |
MYO1E
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Focal segmental glomerulosclerosis 6 |
| RS1882493359 |
DCT
|
Health Risk |
Pathogenic/Likely pathogenic |
Albinism, Oculocutaneous albinism type 8 |
| RS188251941 |
CDH2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS188252400 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS188252826 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1882538642 |
COL4A2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1882542959 |
COL4A2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1882578572 |
KIF5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Myoclonus, intractable |
| RS1882579168 |
KIF5A
|
Health Risk |
Likely pathogenic |
— |
| RS1882585452 |
KIF5A
|
Health Risk |
Likely pathogenic |
Myoclonus, intractable |
| RS188258913 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS188259026 |
CLN8
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis 8, Neuronal ceroid lipofuscinosis 8 |
| RS1882598771 |
KIF5A
|
Health Risk |
Pathogenic |
— |
| RS1882625482 |
IFNG
|
Health Risk |
Pathogenic |
Immunodeficiency 69, Immunodeficiency 69 |
| RS1882640177 |
KIF5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, Spastic paraplegia |
| RS1882641004 |
ERCC5
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum, Xeroderma pigmentosum |
| RS188269446 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS188269735 |
GLDC
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy 1 |
| RS1882701423 |
ERCC5
|
Health Risk |
Pathogenic |
Cerebrooculofacioskeletal syndrome 3, Cerebrooculofacioskeletal syndrome 3 |
| RS188270548 |
NTRK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary insensitivity to pain with anhidrosis, Familial medullary thyroid carcinoma |
| RS188272653 |
GNRHR
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 7 with or without anosmia, Hypogonadotropic hypogonadism 7 with or without anosmia |
| RS188272768 |
NRAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome 6, Noonan syndrome 6 |
| RS188273166 |
SLC30A10
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypermanganesemia with dystonia, polycythemia |
| RS188279654 |
TCOF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Treacher Collins syndrome 1, TCOF1-related disorder |
| RS1882806435 |
ERCC5
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum, Xeroderma pigmentosum group G/Cockayne syndrome |
| RS188280904 |
SETD1B
|
Health Risk |
Conflicting classifications of pathogenicity |
SETD1B-related disorder, SETD1B-related disorder |
| RS188282049 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS188283330 |
COCH
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 9, COCH-related disorder |
| RS188284006 |
SLC6A17
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1882847374 |
POC1B
|
Health Risk |
Pathogenic |
— |
| RS1882854195 |
RPGRIP1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1882855292 |
ERCC5
|
Health Risk |
Pathogenic |
— |
| RS188286943 |
VPS35
|
Health Risk |
Pathogenic |
Parkinson disease 17, Parkinson disease 17 |
| RS1882879689 |
MGAT2
|
Health Risk |
Likely pathogenic |
MGAT2-congenital disorder of glycosylation, MGAT2-congenital disorder of glycosylation |
| RS1882904268 |
RPGRIP1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 6, Leber congenital amaurosis 6 |
| RS1882924778 |
POC1B
|
Health Risk |
Pathogenic |
Cone-rod dystrophy, Cone-rod dystrophy |
| RS1882929478 |
POC1B
|
Health Risk |
Likely pathogenic |
Cone-rod dystrophy 20, Cone-rod dystrophy 20 |
| RS188293278 |
NYX
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS188293910 |
MAGI2
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant tumor of urinary bladder, Malignant tumor of urinary bladder |
| RS1882945917 |
RPGRIP1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1882946937 |
RPGRIP1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 6, Leber congenital amaurosis 6 |
| RS1882968821 |
RPGRIP1
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 13, Leber congenital amaurosis 6 |
| RS1882975083 |
COL4A2
|
Health Risk |
Likely pathogenic |
Porencephaly 2, Porencephaly 2 |
| RS1882993257 |
SYT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome, Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome |
| RS1883001175 |
SGCG
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2C, Autosomal recessive limb-girdle muscular dystrophy type 2C |
| RS188300485 |
HPS4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hermansky-Pudlak syndrome 4, HPS4-related disorder |
| RS1883031542 |
RPGRIP1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1883036406 |
RPGRIP1
|
Health Risk |
Pathogenic |
Cone dystrophy, Cone dystrophy |
| RS1883065804 |
ACADS
|
Health Risk |
Pathogenic |
Deficiency of butyryl-CoA dehydrogenase, Deficiency of butyryl-CoA dehydrogenase |
| RS188308261 |
STX16
|
Health Risk |
Conflicting classifications of pathogenicity |
Pseudohypoparathyroidism type 1B, Inborn genetic diseases |
| RS1883084009 |
RPGRIP1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 6, Cone-rod dystrophy 13 |
| RS188309190 |
CLTC
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS188309404 |
BGN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS188310109 |
MTRFR
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Combined oxidative phosphorylation defect type 7 |